The Dopamine Focus Stack
Bromantane, NALT, DLPA, Vilon and circadian light — a biohacker dopamine-plus-endorphin stack, broken down component by component with the evidence graded honestly.
What's in the Stack
Differentially regulates tyrosine hydroxylase and dopamine/L-DOPA content across brain regions in rats (PMID 17854844). The "printer" the rest of the stack feeds. Guide →
N-acetyl-L-tyrosine is an acetylated form of tyrosine, the amino acid dopamine is built from; tyrosine helps cognition under acute stress (PMID 7794222). Guide →
L-phenylalanine adds substrate; D-phenylalanine is a putative enkephalinase inhibitor (PMID 3515291), the basis for the endorphin "baseline." Guide →
A thymic bioregulator peptide. Its energy/alertness role here is anecdotal only — no controlled human cognitive trial. Guide →
UVB→POMC→beta-endorphin→VTA dopamine is a mechanistic inference, not a proven focus effect. Morning light as circadian hygiene, not a nootropic.
What the Data Shows
Each Piece, and What Backs It
1. Bromantane — the dopamine "printer"
A Russian actoprotector shown in rats to differentially regulate tyrosine-hydroxylase expression and dopamine/L-DOPA content across brain regions (Neuropharmacology 2007, PMID 17854844). Human data is largely Russian asthenia work: a 728-patient multicentre study in psychoautonomic-syndrome asthenia reported 76% responders on CGI-S over 28 days at 50–100 mg/day (PMID 21322821), supported by an earlier Phase-II pilot in psychogenic asthenic disorder (PMID 16995430). Both are real clinical trials, but neither reports a placebo arm, and neither has been replicated in Western trials. Read the full Bromantane guide →
🧪 Buy Bromantane at Swiss Chems →2. NALT / L-Tyrosine — the substrate
N-acetyl-L-tyrosine is an acetylated form of tyrosine — note that intravenous NALT is a poor tyrosine precursor, largely excreted unchanged rather than converted (Metabolism 1989, PMID 2507878). Tyrosine itself restores catecholamine-dependent cognition under acute stress and sleep deprivation (PMID 7794222, 8029265) and feeds the synthesis pathway bromantane accelerates. Full L-Tyrosine guide →
3. DLPA — substrate + endorphin lever
The L-isomer converts toward tyrosine (more dopamine substrate); the D-isomer is a putative enkephalinase inhibitor studied in a primate pain model (Pain 1986, PMID 3515291), the mechanistic basis for a raised endorphin "baseline." New here: our DL-Phenylalanine guide →
4. Vilon — anecdotal, not proven
A short thymic bioregulator peptide (Khavinson). Its "baseline energy and alertness" claim in this stack is anecdotal only — there is no controlled human cognitive trial behind it. Include it knowingly, not because the data supports a focus effect. Full Vilon guide →
🧪 Buy Vilon at Swiss Chems →5. Circadian UV / red light — mechanistic
The proposed chain — UVB → skin/POMC → beta-endorphin → disinhibited VTA dopamine — is mechanistic inference, not a demonstrated focus effect in humans. Treat morning light as circadian hygiene, not a validated nootropic. Use a red/UV panel from a reputable source; we do not send traffic to the device brand named in the original thread.
Key Takeaways
- Bromantane differentially regulated tyrosine hydroxylase and dopamine/L-DOPA content across brain regions in rats after a single dose (PMID 17854844). Separately, Russian clinical trials report an antiasthenic effect in humans — 728 patients, 76% CGI-S responders over 28 days (PMID 21322821) — but these are uncontrolled, with no placebo arm reported.
- Tyrosine is a genuine dopamine precursor that supports cognition under acute stress and sleep deprivation; its N-acetyl form (NALT) is a less efficient precursor (poorly converted in IV studies).
- D-phenylalanine is a plausible enkephalinase inhibitor in preclinical/primate models — a real mechanism for raising endogenous endorphins.
- Every compound in the stack already monetizes and four have full HighPeptides guides, so the internal evidence trail is easy to follow.
- Morning bright light is well-established circadian hygiene independent of any dopamine claim.
- The full five-part stack has NEVER been tested as a combination in any trial — synergy is theoretical, not demonstrated.
- Vilon's focus/energy contribution is anecdotal only — no controlled human cognitive trial supports it.
- The UVB → POMC → beta-endorphin → VTA-dopamine "focus" chain is mechanistic inference, not a proven cognitive effect in humans.
- Bromantane's best data is Russian and sparsely replicated in Western trials; long-term safety data is limited.
- No dosing here is medical advice; there is no validated protocol for combining these five, and interactions are unstudied.
Frequently Asked Questions
Does this stack do anything for a natural user with no PED experience?
Possibly for the substrate legs (tyrosine/NALT, DLPA) and morning light, which act on normal physiology and do not require any prior compound use. Bromantane is the only leg with a distinct dopaminergic mechanism, and even it is best-evidenced for fatigue rather than raw "focus." Vilon and the UV-endorphin idea remain anecdotal/mechanistic for everyone, PED-experienced or not.
Is bromantane a stimulant?
No — it is classed as an actoprotector, not a stimulant. What the cited work actually shows: a single oral dose differentially regulates tyrosine hydroxylase and dopamine/L-DOPA content across rat brain regions (PMID 17854844) — a synthesis-side mechanism rather than the release/reuptake spike of amphetamine. In humans, the antiasthenic effect emerged by day 3 and persisted a month after withdrawal (PMID 21322821), though the Phase-II pilot reported that on single administration a psychostimulant effect predominated (PMID 16995430). No study has measured dopamine synthesis capacity over days in humans, so treat the "baseline rather than a jolt" framing as mechanistic inference, not a demonstrated time course.
What is the difference between NALT and DLPA in this stack?
NALT (N-acetyl-L-tyrosine) is one step downstream — tyrosine is the direct dopamine precursor. DLPA sits one step further back: its L-isomer converts toward tyrosine, and its D-isomer adds a separate endorphin-preserving action that tyrosine does not have.
Is Vilon proven to improve focus?
No. Vilon is a thymic bioregulator peptide, and its reported "baseline energy and alertness" in this context is anecdotal — there is no controlled human cognitive trial demonstrating a focus benefit. It is included in the stack on user report, not clinical evidence.
Do I actually need the UV / red-light component?
The dopamine benefit of light here is mechanistic inference, not a demonstrated effect. Morning bright-light exposure is worth doing anyway for circadian rhythm and mood, but treat it as circadian hygiene rather than a validated part of a nootropic stack.
🧪 Buy Bromantane — Research Grade
Swiss Chems publishes third-party HPLC COAs for selected products — vendor-published, a claim to verify. Deep-linked to the Bromantane product page.
Buy Bromantane at Swiss Chems →Affiliate links — support HighPeptides at no extra cost.
🛒 Recommended Products
Support supplements and gear relevant to this protocol.
Affiliate links — support HighPeptides at no extra cost.
📚 Related HighPeptides Research
Peer-Reviewed References
47-page guide: protocols, dosing, sourcing — everything in one place.
Get the guide — $19 (normally $29) → New to peptides? Start with the $19 Buyer’s Playbook → All ebooks & guides →Educational purposes only. Not medical advice.
This stack has not been tested as a combination in any clinical trial. Compounds discussed are for research/educational purposes; several (bromantane, Vilon) are not approved dietary supplements or drugs in the US. Always consult a qualified healthcare provider before using any compound.